Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery
鈥嬧嬧嬧嬧嬧嬧婣 major clinical trial, led by the University of 91制片厂, has revealed survival rates for patients with operable bladder cancer are significantly improved by adding an immunotherapy drug to before and after surgery.